Indian Journal of Rheumatology

该期刊要求在投稿过程中列出每位作者的贡献,并在致谢部分之后加入作者贡献标题,该信息将在校对阶段显示在作者贡献标题下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊致力于促进研究的开放性、透明度和可重复性,鼓励作者在适当的伦理和法律考虑下,将研究数据共享在相关的公共数据存储库中,并包含链接到数据的数据可用性声明;如果无法共享数据,则使用声明确认无法共享的原因,并在研究中引用该数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求在指定标题下包含伦理批准声明,即使已在方法部分包含伦理批准信息;如果不需要伦理批准,则需明确声明;所有报告涉及人类参与者、人类数据或人类组织的研究的论文必须声明相关伦理委员会或机构审查委员会批准了研究,或豁免了批准要求,并提供审查委员会的全名和机构以及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

《印度风湿病学杂志》是一本开放获取、同行评审的期刊,所有被接受的文章在出版后立即免费在线提供,采用知识共享许可,并永久在线托管;目前在该期刊发表没有文章处理费(APC)。 模型中文摘要

Indian Journal of Rheumatology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. There are currently no Article Processing Charges (APCs) to publish in this journal. For general information on open access at Sage please visit the Open Access …

该期刊采用双匿名同行评审流程,审稿人与编辑/副编辑互动,不公布审稿信息;稿件将经过初步评估,如果不符合指南要求,将在同行评审前退回修改;如果超出期刊范围或其他不合适,稿件可能在此时被直接拒稿而无需同行评审。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency:Double Anonymized Reviewer interacts with: Editor/Associate Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts m…

IJR致力于只发表诚实的原创作品,任何形式的剽窃都被非常严肃地对待;被识别为剽窃的稿件将被拒稿,或在发表后被撤回,并正式通知机构负责人和/或其他相关当局;为检测剽窃,您的文章在提交后可能会被软件检查。 模型中文摘要

IJR strives to publish only honest original work, and any form of plagiarism is viewed very seriously. The manuscripts identified such would be rejected/ after publication would be retracted with formal communication to the head of institution and/or other relevant authorities. To detect plagiarism, your article may be checked by softwares after submission. Data availability The Journal is committ…

该期刊将考虑已在预印本服务器上发布的稿件;请在投稿时在指定字段中输入预印本DOI;建议您在提交时告知期刊编辑部您已发布的预印本;注意在同行评审期间不应在预印本服务器上发布稿件的更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循ICMJE要求,临床试验必须在WHO批准的公共试验注册处注册,注册时间不晚于首例参与者入组时间,作为考虑发表的条件;试验注册处名称和URL以及注册编号必须包含在摘要末尾。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.